Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
68,958,635
-
Total 13F shares
-
33,334,567
-
Share change
-
-24,168
-
Total reported value
-
$81,640,055
-
Put/Call ratio
-
7%
-
Price per share
-
$2.45
-
Number of holders
-
66
-
Value change
-
-$481,138
-
Number of buys
-
26
-
Number of sells
-
28
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q4 2022
As of 31 Dec 2022 Olema Pharmaceuticals, Inc. - Common Stock (OLMA) had 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,334,567 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Logos Global Management LP, JANUS HENDERSON GROUP PLC, Cormorant Asset Management, LP, Kynam Capital Management, LP, Vivo Capital, LLC, VANGUARD GROUP INC, SECTORAL ASSET MANAGEMENT INC, CITADEL ADVISORS LLC, and BlackRock Inc..
This table shows 66 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.